BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
CASP8 |
Q14790
|
caspase 8
|
Enzyme
|
3.7E-06 |
0.404 |
0.923 |
CD274 |
Q9NZQ7
|
CD274 molecule
|
Receptor
|
1.9E-02 |
0.324 |
0.923 |
CDH1 |
P12830
|
cadherin 1
|
|
0.15 |
0.401 |
0.808 |
CDK4 |
P11802
|
cyclin dependent kinase 4
|
Kinase
|
6.3E-02 |
0.412 |
0.808 |
CDKN1B |
P46527
|
cyclin dependent kinase inhibitor 1B
|
|
0.62 |
0.409 |
0.769 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CKAP4 |
Q07065
|
cytoskeleton associated protein 4
|
|
0.51 |
0.436 |
0.731 |
CXCL12 |
P48061
|
C-X-C motif chemokine ligand 12
|
|
0.12 |
0.379 |
0.846 |
DNMT1 |
P26358
|
DNA methyltransferase 1
|
Epigenetic regulator
|
1.00 |
0.406 |
0.885 |
EGFR |
P00533
|
epidermal growth factor receptor
|
Kinase
|
0.37 |
0.295 |
0.885 |
HMGA2 |
P52926
|
high mobility group AT-hook 2
|
Nucleic acid binding
|
0.87 |
0.429 |
0.808 |
KIT |
P10721
|
KIT proto-oncogene, receptor tyrosine kinase
|
Kinase
|
0.98 |
0.366 |
0.808 |
KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |
MCL1 |
Q07820
|
MCL1 apoptosis regulator, BCL2 family member
|
Signaling
|
0.96 |
0.430 |
0.808 |
MDM2 |
Q00987
|
MDM2 proto-oncogene
|
Nucleic acid binding
|
1.00 |
0.362 |
0.846 |
POU5F1 |
Q01860
|
POU class 5 homeobox 1
|
|
0.95 |
0.441 |
0.846 |
POU5F1P3 |
|
POU class 5 homeobox 1 pseudogene 3
|
|
|
0.452 |
0.808 |
POU5F1P4 |
|
POU class 5 homeobox 1 pseudogene 4
|
|
|
0.452 |
0.808 |
RPE65 |
Q16518
|
retinoid isomerohydrolase RPE65
|
Enzyme
|
6.5E-14 |
0.417 |
0.808 |
SOX2 |
P48431
|
SRY-box transcription factor 2
|
Transcription factor
|
0.71 |
0.405 |
0.808 |
TNFRSF10B |
O14763
|
TNF receptor superfamily member 10b
|
|
2.0E-04 |
0.505 |
0.769 |
TP53 |
P04637
|
tumor protein p53
|
Transcription factor
|
0.53 |
0.236 |
0.962 |
TP63 |
Q9H3D4
|
tumor protein p63
|
Transcription factor
|
1.00 |
0.362 |
0.769 |
UVRAG |
Q9P2Y5
|
UV radiation resistance associated
|
|
0.99 |
0.436 |
0.769 |